Olanzapina Zentiva (Olanzapine)

Olanzapine, the active ingredient in Olanzapina Zentiva, is an atypical antipsychotic presented as a unknown/unknown for oral use. It treats schizophrenia and bipolar disorder in adults and adolescents. GNH USA supplies Olanzapina Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olanzapina Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olanzapine is an atypical antipsychotic that modulates neurotransmitter activity in several psychiatric disorders.

- Schizophrenia: helps  to reduce  the positive and  negative symptoms of the disease. - Bipolar I disorder :  stabil  the  mood  and  prevent  de  mania  episodes  for  the  patient. - Acute  acute  t                                   ...     ...   …  …  …  …  …  …  …  … …  ...  … …  … …  …  …  …  …  …  ...

Olanzapine may present a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Weight gain - Sedation - Dry mouth - Constipation - Increased appetite - Dizziness

Serious or Rare Side Effects: - Neuroleptic malignant syndrome - Tardive dyskinesia - Severe hyperglycaemia - Agranulocytosis    - Seizures  - Myocardial infarction 

When  ​           … … …  …  … … … …  …  …  …  …  ...